KKR co-leads over $125M series C round of Paige.AI

KKR & Co. Inc., through its Health Care Strategic Growth Fund, co-led an approximately $125 million series C funding round for Paige.AI Inc., alongside Casdin Capital LLC and Johnson & Johnson Innovation - JJDC Inc.

Catalio Capital Management LP also participated in the round.

Paige, a provider of artificial intelligence-based diagnostic software in pathology, will use the new capital to expand its geographic footprint.